高血压合并左心室肥厚诊治专家共识

2019-11-12 中国心血管相关专家小组(统称) 中华心血管病杂志 ( 网络版),2019,2:e1000000.

左心室肥厚(left ventricular hypertrophy,LVH)是一种心室壁增厚、心肌重量增加和心肌重塑的心肌变化现象。高血压是导致LVH 的最重要原因,此外,老年人、肥胖、遗传、饮酒和高盐膳食等也是LVH 的危险因素。我国一项基层社区横断面调查结果显示,42.7% 的高血压患者伴有LVH。高血压和LVH 都是心脑血管疾病的独立危险因素,LVH 显著增加高血压患者的冠状动脉粥样硬化性

中文标题:

高血压合并左心室肥厚诊治专家共识

发布日期:

2019-11-12

简要介绍:

左心室肥厚(left ventricular hypertrophy,LVH)是一种心室壁增厚、心肌重量增加和心肌重塑的心肌变化现象。高血压是导致LVH 的最重要原因,此外,老年人、肥胖、遗传、饮酒和高盐膳食等也是LVH 的危险因素。我国一项基层社区横断面调查结果显示,42.7% 的高血压患者伴有LVH。高血压和LVH 都是心脑血管疾病的独立危险因素,LVH 显著增加高血压患者的冠状动脉粥样硬化性心脏病、心力衰竭、卒中和死亡风险。反之,有效管理血压和逆转LVH,能显著降低心血管事件及死亡风险。本共识提供简化的LVH 筛查和诊断流程,目的是推动高血压合并LVH 的规范化管理。

 

拓展指南:高血压相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=高血压合并左心室肥厚诊治专家共识)] GetToolGuiderByIdResponse(projectId=1, id=ab3ce1c001839e75, title=高血压合并左心室肥厚诊治专家共识, enTitle=, guiderFrom=中华心血管病杂志 ( 网络版),2019,2:e1000000., authorId=null, author=, summary=左心室肥厚(left ventricular hypertrophy,LVH)是一种心室壁增厚、心肌重量增加和心肌重塑的心肌变化现象。高血压是导致LVH 的最重要原因,此外,老年人、肥胖、遗传、饮酒和高盐膳食等也是LVH 的危险因素。我国一项基层社区横断面调查结果显示,42.7% 的高血压患者伴有LVH。高血压和LVH 都是心脑血管疾病的独立危险因素,LVH 显著增加高血压患者的冠状动脉粥样硬化性, cover=, journalId=null, articlesId=null, associationId=306, associationName=中国心血管相关专家小组(统称), associationIntro=本制定者非特指某个专家小组,为统称。, copyright=0, guiderPublishedTime=Tue Nov 12 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>左心室肥厚(left ventricular hypertrophy,LVH)是一种心室壁增厚、心肌重量增加和心肌重塑的心肌变化现象。高血压是导致LVH 的最重要原因,此外,老年人、肥胖、遗传、饮酒和高盐膳食等也是LVH 的危险因素。我国一项基层社区横断面调查结果显示,42.7% 的高血压患者伴有LVH。高血压和LVH 都是心脑血管疾病的独立危险因素,LVH 显著增加高血压患者的冠状动脉粥样硬化性心脏病、心力衰竭、卒中和死亡风险。反之,有效管理血压和逆转LVH,能显著降低心血管事件及死亡风险。本共识提供简化的LVH 筛查和诊断流程,目的是推动高血压合并LVH 的规范化管理。 </P> <P> </P>拓展指南:<strong>与<font color=red>高血压</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=f12f51c0018319dd" title="2019 AHA/ACC报告:成人高血压的临床表现和质量指标" target=_blank>2019 AHA/ACC报告:成人高血压的临床表现和质量指标</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0fe651c00182380d" title="2019年日本高血压管理指南解读" target=_blank>2019年日本高血压管理指南解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=e4e8a1c0018232c4" title="2019 专家共识:中国中青年人群高血压的管理" target=_blank>2019 专家共识:中国中青年人群高血压的管理</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=2386b1c001812a63" title="ICH E12:抗高血压新药临床评价原则" target=_blank>ICH E12:抗高血压新药临床评价原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6bc1e1c001e90941" title="高血压基层诊疗指南(实践版·2019)" target=_blank>高血压基层诊疗指南(实践版·2019)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%AB%98%E8%A1%80%E5%8E%8B" target=_blank>有关高血压更多指南</a></ul>, tagList=[TagDto(tagId=98018, tagName=高血压合并左心室肥厚)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4355, appHits=390, showAppHits=5, pcHits=2610, showPcHits=2763, likes=69, shares=18, comments=8, approvalStatus=1, publishedTime=Fri Dec 20 23:15:29 CST 2019, publishedTimeString=2019-11-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 20 23:15:29 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:19:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=高血压合并左心室肥厚诊治专家共识)])
高血压合并左心室肥厚诊治专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=925175, encodeId=12169251e5eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:44:40 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913876, encodeId=89329138e600, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=227a1940506, createdName=lyzy, createdTime=Tue Jan 05 14:32:18 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888891, encodeId=07a288889108, content=仔细看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:58 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888890, encodeId=96258888907d, content=左室肥厚资料不多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:41 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888889, encodeId=ed4c88888978, content=资料不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:22 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-02-18 ms4000001482550161

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=925175, encodeId=12169251e5eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:44:40 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913876, encodeId=89329138e600, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=227a1940506, createdName=lyzy, createdTime=Tue Jan 05 14:32:18 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888891, encodeId=07a288889108, content=仔细看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:58 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888890, encodeId=96258888907d, content=左室肥厚资料不多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:41 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888889, encodeId=ed4c88888978, content=资料不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:22 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-01-05 lyzy

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=925175, encodeId=12169251e5eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:44:40 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913876, encodeId=89329138e600, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=227a1940506, createdName=lyzy, createdTime=Tue Jan 05 14:32:18 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888891, encodeId=07a288889108, content=仔细看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:58 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888890, encodeId=96258888907d, content=左室肥厚资料不多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:41 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888889, encodeId=ed4c88888978, content=资料不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:22 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-09-28 ms5000001961239662

    仔细看看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=925175, encodeId=12169251e5eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:44:40 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913876, encodeId=89329138e600, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=227a1940506, createdName=lyzy, createdTime=Tue Jan 05 14:32:18 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888891, encodeId=07a288889108, content=仔细看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:58 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888890, encodeId=96258888907d, content=左室肥厚资料不多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:41 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888889, encodeId=ed4c88888978, content=资料不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:22 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-09-28 ms5000001961239662

    左室肥厚资料不多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=925175, encodeId=12169251e5eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210218/994a038e370045d8944a573fa77e3034/3cf31c7b86844fbc9b4b755e348eb533.jpg, createdBy=3af25452664, createdName=ms4000001482550161, createdTime=Thu Feb 18 00:44:40 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913876, encodeId=89329138e600, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=227a1940506, createdName=lyzy, createdTime=Tue Jan 05 14:32:18 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888891, encodeId=07a288889108, content=仔细看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:58 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888890, encodeId=96258888907d, content=左室肥厚资料不多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:41 CST 2020, time=2020-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888889, encodeId=ed4c88888978, content=资料不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=200a5398171, createdName=ms5000001961239662, createdTime=Mon Sep 28 12:38:22 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-09-28 ms5000001961239662

    资料不错

    0